MedKoo Cat#: 206091 | Name: Supinoxin
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Supinoxin, also known as RX-5902, is an orally bioavailable small molecule inhibitor of phosphorylated-p68 RNA helicase (P-p68), with potential anti-proliferative and antineoplastic activity. Upon oral administration, P-p68 inhibitor RX-5902 may both inhibit the activity of the anti-apoptotic B-cell lymphoma 2 (Bcl-2) protein and facilitate the induction of cyclin-dependent kinase inhibitor 1 (p21). This may prevent G2/M cell cycle progression and lead to growth inhibition in tumor cells. P-p68 is overexpressed in various types of solid tumors but absent in normal tissues, and plays a role in tumor progression and metastasis.

Chemical Structure

Supinoxin
Supinoxin
CAS#888478-45-3

Theoretical Analysis

MedKoo Cat#: 206091

Name: Supinoxin

CAS#: 888478-45-3

Chemical Formula: C22H24FN5O4

Exact Mass: 441.1812

Molecular Weight: 441.46

Elemental Analysis: C, 59.86; H, 5.48; F, 4.30; N, 15.86; O, 14.50

Price and Availability

Size Price Availability Quantity
5mg USD 250.00 2 Weeks
10mg USD 450.00 2 Weeks
100mg USD 1,850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Supinoxin; RX5902; RX5902; RX 5902.
IUPAC/Chemical Name
4-(3,5-dimethoxyphenyl)-N-(7-fluoro-3-methoxyquinoxalin-2-yl)piperazine-1-carboxamide
InChi Key
KAKPGJJRYRYSTP-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H24FN5O4/c1-30-16-11-15(12-17(13-16)31-2)27-6-8-28(9-7-27)22(29)26-20-21(32-3)25-18-5-4-14(23)10-19(18)24-20/h4-5,10-13H,6-9H2,1-3H3,(H,24,26,29)
SMILES Code
O=C(N1CCN(C2=CC(OC)=CC(OC)=C2)CC1)NC3=NC4=CC(F)=CC=C4N=C3OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
        
Product Data
Certificate of Analysis
Safety Data Sheet (SDS)
Biological target:
Supinoxin targets the Y593 phospho-p68 RNA helicase and exhibits potent antiproliferative effects.
In vitro activity:
To Be Determined
In vivo activity:
To Be Determined
Solvent mg/mL mM
Solubility
DMSO 100.0 226.52
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 441.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
Song YK, Seol YH, Kim MJ, Jeong JW, Choi HI, Lee SW, Chae YJ, Ahn S, Gong YD, Lee KR, Koo TS. Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats. Pharmaceutics. 2021 Mar 11;13(3):373. doi: 10.3390/pharmaceutics13030373. PMID: 33799884; PMCID: PMC7998731.
In vitro protocol:
To Be Determined
In vivo protocol:
Song YK, Seol YH, Kim MJ, Jeong JW, Choi HI, Lee SW, Chae YJ, Ahn S, Gong YD, Lee KR, Koo TS. Pharmacokinetic Characterization of Supinoxin and Its Physiologically Based Pharmacokinetic Modeling in Rats. Pharmaceutics. 2021 Mar 11;13(3):373. doi: 10.3390/pharmaceutics13030373. PMID: 33799884; PMCID: PMC7998731.
1: Kost GC, Yang MY, Li L, Zhang Y, Liu CY, Kim DJ, Ahn CH, Lee YB, Liu ZR. A Novel Anti-Cancer Agent, 1-(3,5-Dimethoxyphenyl)-4-[(6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl] piperazine (RX-5902),Interferes with β-Catenin Function through Y593 phospho-p68RNA Helicase. J Cell Biochem. 2015 Feb 3. doi: 10.1002/jcb.25113. [Epub ahead of print] PubMed PMID: 25649741.